GSK and AnaptysBio Enter Legal Battle Over Cancer Drug Jemperli

GSK subsidiary Tesaro and AnaptysBio file dueling lawsuits in Delaware court over alleged breaches of their 2014 Jemperli licensing agreement, with trial set for July 2026.